Please login to the form below

pulmonary embolism

This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.

This was abandoned in 2016 after two patients died in a phase 3 trial of the drug after suffering a pulmonary embolism.

Boston Scientific makes $4.2bn play for UK’s BTG

Boston Scientific’s chief executive Michael Mahoney highlighted BTG’s cancer and pulmonary embolism portfolios – which include products to freeze and deliver radiotherapy or drugs to tumours and devices to dissolve
AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.
FDA panel undermines Lilly and Incyte’s baricitinib hopes

baricitinib’s potential to cause side effects such as pulmonary embolism and venous thromboembolism.
AbbVie’s JAK inhibitor upadacitinib clears another phase III trial

There was a fatality from a stroke in the trial in a patient, plus one case of a pulmonary embolism, although AbbVie said these occurred in at-risk patients.
Xarelto beats aspirin for recurrent blood clots

Janssen's parent company Johnson &Johnson (J&J) said in a statement that up to 10% of people who have suffered a VTE (usually a deep vein thrombosis or pulmonary embolism)

More from news
Approximately 2 fully matching, plus 46 partially matching documents found.

Modern anticoagulants threaten status quo

embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Thrombectomy System Market to Exhibit Steadfast Expansion During 2015 - 2025

Due to its versatility, the thrombectomy system can be utilized in several different applications like acute myocardial infraction (AMI), peripheral arterial disease (PAD), deep vein thrombosis (DVT), pulmonary embolism (PE), and
Micro Guide Catheters Market Future Trends and Key Industry Analysis of Industry by 2020

Micro guide catheter tips are capable of reaching intricate anatomy to treat diseases such as uterine fibroids, arterial embolism, venal or pulmonary embolism, vascular malformations and hypervascularized tumors.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Senior Account Director development role to Business Director, H...: Excellent package

Global Business Development Director – Health Education: excellent commission

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Add my company

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...